These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[ ]
|
Preliminary Proxy Statement
|
|
[ ]
|
Confidential, For Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
|
|
[X]
|
Definitive Proxy Statement
|
|
[ ]
|
Definitive Additional Materials
|
|
[ ]
|
Soliciting Material Pursuant to §240.14a-12
|
|
[X]
|
No fee required.
|
|
|
[ ]
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11.
|
|
|
|
(1)
|
Title of each class of securities to which transaction
applies:
|
|
|
|
|
|
|
(2)
|
Aggregate number of securities to which transaction
applies:
|
|
|
|
|
|
|
(3)
|
Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which
the filing fee is calculated and state how it was
determined):
|
|
|
|
|
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
|
|
|
|
|
(5)
|
Total fee paid:
|
|
|
|
|
|
[ ]
|
Fee paid previously with preliminary materials.
|
|
|
[ ]
|
Check box if any part of the fee is offset as provided by Exchange
Act Rule 0-11(a)(2) and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing by
registration statement number, or the Form or Schedule and the date
of its filing.
|
|
|
|
(1)
|
Amount Previously Paid:
|
|
|
|
|
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
|
|
|
|
|
(3)
|
Filing Party:
|
|
|
|
|
|
|
(4)
|
Date Filed:
|
|
Name
|
|
Served as
Director Since
|
|
Age
|
|
Principal Business Experience
|
|
|
|
|
|
|
|
|
|
Guy Dubois
|
|
2012
|
|
59
|
|
Guy Dubois
became a director in
December 2012, and has served as our Chairman since February 2013.
Mr. Dubois also served as a member of the Company’s Executive
Committee from October 2012 to September 2016, and was appointed to
serve as Chief Executive Officer of the Company in September 2016,
which position he held through December 31, 2017. Mr. Dubois is a
director of Singapore-based Tetra House Pte. Ltd., a provider of
consulting and advisory services worldwide. Mr. Dubois is a former
director and chief executive officer of Gategroup AG, and also
previously held various executive leadership roles at Gate Gourmet
Holding LLC. Mr. Dubois has held executive management positions at
Roche Vitamins Inc. in New Jersey, as well as regional management
roles in that firm’s Asia Pacific operations. Mr. Dubois also
served the European Organization for Nuclear Research (CERN) team
in Switzerland in various roles, including treasurer and chief
accountant. Additionally, Mr. Dubois worked with IBM in Sweden as
Product Support Specialist for Financial Applications. A Belgian
citizen, Mr. Dubois holds a degree in financial science and
accountancy from the Limburg Business School in Diepenbeek,
Belgium.
When considering Mr. Dubois as a director of the Company, the Board
reviewed his extensive financial and management expertise and
experience, as well as the fact that he served as the
Company’s CEO for approximately 4 years.
|
|
|
|
|
|
|
|
|
|
Karen Macleod
|
|
2016
|
|
54
|
|
Ms.
Macleod
became a director of the Company in
January 2016 and currently serves as chief executive officer of
Arete Group LLC, a professional services firm. Prior to Arete
Group, Ms. Macleod was President of Tatum LLC, a New York-based
professional services firm owned by Randstad, from 2011 to 2014,
and was a co-founder of Resources Connection (NASDAQ:RECN), now
known as RGP, a multinational professional services firm founded as
a division of Deloitte in June 1996. Ms. Macleod served in several
positions for RGP, including as a director from 1999 to 2009 and
President, North America from 2004 to 2009. Prior to RGP, Ms.
Macleod held several positions in the audit department of Deloitte
from 1985 to 1994. Ms. Macleod served as a director for A-Connect
(Schweiz) AG, a privately held, Swiss-based global
professional services firm, from 2014-2016, and was a director for
Overland Solutions from 2006 to 2013. Currently, Ms. Macleod is
serving as a director on the Board of the FWA (Financial
Women’s Association) in New York, and is a member of their
audit committee. Ms. Macleod holds a Bachelor of Science in
Business/Managerial Economics from the University of California,
Santa Barbara.
The Board believes Ms. Macleod’s senior public company
leadership experience along with her finance and accounting
background are important to the ongoing growth of the Company and
corporate governance excellence.
|
|
|
|
|
|
|
|
|
|
Karim Sehnaoui
|
|
2018
|
|
39
|
|
Mr. Sehnaoui became a director of the Company in February 2018. Mr.
Sehnaoui is an entrepreneur and investment professional, who
specializes in private equity, venture capital, and corporate
finance. Currently, he serves as General Manager of the Reference
Group SARL, a boutique financial advisory firm based in Geneva,
Switzerland, which position he has held since October 2017, and as
a Director of ETS Limited. In addition, Mr. Sehnaoui is the founder
and current Managing Director of Elham Management and Investment
Group, an investment firm founded in 2011 that is dedicated to
sustainable strategic investing. From 2012 to 2016, Mr. Sehnaoui
taught graduate level finance courses as a visiting Assistant
Professor at MSB Mediterranean School of Business in Tunisia. Prior
to that, Mr. Sehnaoui spent several years in investment banking and
private equity, serving as Acting Chief Investment Officer of Abu
Dhabi Investment House PJSC and General Manager for Abu Dhabi
Investment House S.A., and Business Development Director at Ithmaar
Bank. Mr. Sehnaoui is currently a member of the Supervisory Board
of Fyber N.V. (FRA: FBEN), an advertising technology company. Mr.
Sehnaoui holds Bachelor’s and Master’s degrees in Civil
Engineering from McGill University in Montreal, Canada, and was a
Global Leadership Fellow at the World Economic Forum in Geneva,
Switzerland from 2005 to 2007.
The Board’s decision to appoint Mr. Sehnaoui as a director of
the Company was made in connection with ETS Limited becoming the
Company’s largest shareholder of record. The Board also
believes Mr. Sehnaoui’s senior leadership experience, along
with his private equity and venture capital background, are
important to the ongoing growth of the Company and corporate
governance.
|
|
|
2017
|
2016
|
|
|
|
|
|
Audit Fees
(1)
|
$
162,420
|
$
155,552
|
|
Audit-Related Fees
(2)
|
$
6,141
|
$
1,863
|
|
Tax Fees
(3)
|
$
20,728
|
$
24,415
|
|
All Other Fees
(4)
|
$
21,661
|
$
-
|
|
Total
|
$
210,950
|
$
181,830
|
|
(1)
|
Audit services in 2017 and 2016 consisted of the audit of our
annual consolidated financial statements, and other services
related to filings and registration statements filed by us and our
subsidiaries, and other pertinent matters. Eide Bailly has served
as our independent registered public accounting firm since
September 24, 2013.
|
|
(2)
|
Audit-related fees consisted of travel costs related to our annual
audit.
|
|
(3)
|
For permissible professional services related to income tax return
preparation and compliance.
|
|
(4)
|
All other fees are related to the preparation of the
Company’s Affordable Care Act forms and examination of the
401(k) financial statements.
|
|
|
Respectfully Submitted,
Eric Rosenblum
Dirk Karel J. van Daele
Karen Macleod
|
|
|
|
|
Name
|
|
Age
|
|
Position
|
|
Derek Cassell
|
|
44
|
|
Chief Executive Officer and former President
|
|
Guy Dubois
|
|
59
|
|
Chairman and former Chief Executive Officer
|
|
Peter K. Poli
|
|
56
|
|
Chief Financial Officer
|
|
Name and
|
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
All Other Compensation
|
Total
|
|
Principal Position
|
Year
|
($)
|
($)
|
($)
(1)
|
($)
(2)
|
($)
(3)
|
($)
|
|
|
|
|
|
|
|
|
|
|
Guy Dubois
(4)
|
2017
|
-
|
-
|
$
100,000
|
-
|
-
|
$
100,000
|
|
Chairman and Former Chief Executive Officer
|
2016
|
-
|
-
|
$
30,000
|
$
170,182
|
-
|
$
200,182
|
|
|
|
|
|
|
|
|
|
|
Derek Cassell
(5)
|
2017
|
$
224,454
|
-
|
$
193,846
|
-
|
$
351
|
$
418,651
|
|
Chief Executive Officer and Former President
|
2016
|
$
206,076
|
-
|
$
42,500
|
-
|
-
|
$
248,576
|
|
|
|
|
|
|
|
|
|
|
Peter Poli
(6)
|
2017
|
$
175,384
|
-
|
-
|
$
134,318
|
-
|
$
309,702
|
|
Chief Financial Officer
|
2016
|
-
|
-
|
-
|
-
|
-
|
-
|
|
(1)
|
This
column represents the
grant date fair value in accordance with ASC 718. These amounts do
not represent the actual value that may be realized by the named
executive officers. $25,000 of Mr. Dubois’ stock award
payment had been accrued, but had not yet been issued as of
September 30, 2017.
|
|
(2)
|
This column represents the grant date fair value in accordance with
ASC 718. Please refer to the section labeled
“Stock-Based Compensation” found within Note 2,
“Summary of Significant Accounting Policies,” in the
Notes to Consolidated Financial Statements included in our Annual
Report on Form 10-K filed on December 19, 2017 for the
relevant assumptions used to determine the compensation cost of our
stock option awards. These amounts do not represent the actual
value, if any, that may be realized by the named executive
officers.
|
|
(3)
|
All other compensation includes health club membership for Mr.
Cassell.
|
|
(4)
|
Mr. Dubois served as a member of the Executive Committee from
October 2012 to September 2016, and as the Chief Executive Officer
from September 2016 to December 2017. He currently serves as the
Chairman of the Board of Directors.
|
|
(5)
|
On January 1, 2018, Mr. Cassell was appointed as the
Company’s Chief Executive Officer. Mr. Cassell previously
served as the Company’s President from December 19, 2016 to
January 1, 2018.
|
|
(6)
|
Mr. Poli began serving as our Chief Financial Officer on January 3,
2017 and, as such, did not receive any compensation from the
Company during fiscal 2016.
|
|
Name
|
Number
of securities underlying unexercised options (#)
exercisable
|
Number
of securities underlying unexercised options (#)
unexercisable
|
Equity
incentive plan awards: Number of underlying unexercised unearned
options (#)
|
Option
exercise price ($) (1) |
Option
expiration
date
(2)
|
Number of shares or units of stock that have not vested
(#)
|
Market
value of shares or units of stock that have not vested
($)
|
Equity
incentive plan awards: Number of Unearned shares, units or other
rights that have not vested (#)
|
Equity
incentive plan awards: Market or Payout value of unearned shares,
units or other rights that have not vested ($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Guy
Dubois
|
2,385
|
-
|
-
|
$
12.58
|
3/21/2022
|
-
|
-
|
-
|
-
|
|
|
64,665
|
-
|
-
|
$
9.00
|
4/14/2022
|
-
|
-
|
-
|
-
|
|
|
4,083
|
-
|
-
|
$
14.70
|
6/30/2022
|
-
|
-
|
-
|
-
|
|
|
2,280
|
-
|
-
|
$
19.46
|
9/30/2022
|
-
|
-
|
-
|
-
|
|
|
2,344
|
-
|
-
|
$
19.29
|
12/31/2023
|
-
|
-
|
-
|
-
|
|
|
2,432
|
-
|
-
|
$
18.75
|
3/31/2023
|
-
|
-
|
-
|
-
|
|
|
51,576
|
-
|
-
|
$
17.45
|
6/02/2023
|
-
|
-
|
-
|
-
|
|
|
2,647
|
-
|
-
|
$
15.45
|
6/30/2023
|
-
|
-
|
-
|
-
|
|
|
14,988
|
-
|
-
|
$
12.01
|
1/27/2022
|
-
|
-
|
-
|
-
|
|
|
8,868
|
-
|
-
|
$
10.15
|
4/20/2022
|
-
|
-
|
-
|
-
|
|
|
113,310
|
-
|
-
|
$
9.65
|
8/14/2022
|
-
|
-
|
-
|
-
|
|
|
8,571
|
-
|
-
|
$
10.50
|
9/30/2022
|
-
|
-
|
-
|
-
|
|
|
12,676
|
-
|
-
|
$
5.95
|
10/14/2022
|
-
|
-
|
-
|
-
|
|
|
15,126
|
-
|
-
|
$
5.95
|
1/15/2023
|
-
|
-
|
-
|
-
|
|
|
14,286
|
-
|
-
|
$
6.30
|
3/31/2023
|
-
|
-
|
-
|
-
|
|
|
18,000
|
-
|
-
|
$
5.00
|
6/30/2023
|
-
|
-
|
-
|
-
|
|
|
|
|
|
|
|
11,468
(3)
|
16,399
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Peter
Poli
|
50,000
|
50,000
(4)
|
-
|
$
3.75
|
1/1/2022
|
-
|
-
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
Derek
Cassell
|
-
|
-
|
-
|
-
|
-
|
30,000
(5)
|
42,900
|
-
|
-
|
|
(1)
|
This table reports the exercise prices of the stock options
reported therein as of September 30, 2017. However, on November 30,
2017, the Board of Directors approved of the repricing of all
outstanding stock options and warrants currently held by the
Company’s officers and directors. As such, all of the stock
options reported in this table now have an exercise price of $1.24,
the closing price of the Company’s Common Stock as reported
by the OTCQX Marketplace on November 30, 2017.
|
||||||||
|
(2)
|
On May 11, 2017, the Board of Directors extended the warrant
expiration date of current board members and certain employees by 5
years. The dates included in this table reflect the expiration
dates after such extension.
|
||||||||
|
(3)
|
Represents
the number of shares,
equaling $25,000, which have not yet been issued to Mr. Dubois for
his services on the Board for the quarter ended September 30,
2017.
|
||||||||
|
(4)
|
Such shares are scheduled to vest on January 1, 2019.
|
||||||||
|
(5)
|
Such shares are scheduled to vest on March 30, 2018.
|
||||||||
|
|
Fees earned
|
Stock awards
|
Warrant awards
|
Cash
|
Total
|
|
Name
(1)
|
($)
(2)
|
($)
|
($)
|
($)
|
($)
|
|
|
|
|
|
|
|
|
David
Boone
|
$
100,000
|
$
100,000
|
-
|
-
|
$
100,000
|
|
Karen
Macleod
|
$
100,000
|
-
|
$
100,000
|
-
|
$
100,000
|
|
Dirk
van Daele
|
$
100,000
|
$
75,000
|
-
|
$
25,000
|
$
100,000
|
|
Dr.
Ray Johnson
|
$
100,000
|
-
|
$
100,000
|
-
|
$
100,000
|
|
Eric
Rosenblum
|
$
100,000
|
$
100,000
|
-
|
-
|
$
100,000
|
|
(1)
|
As discussed above, Messrs. Boone, van Daele, Rosenblum and Johnson
resigned from their positions as directors on the Company’s
Board of Directors effective May 31, 2018. Additionally, Mr.
Sehnaoui was appointed to serve as a director on the Board on
February 7, 2018.
|
|
(2)
|
Fees earned by our non-employee directors were paid in cash,
Common Stock or warrants at the option of the director. A liability
of $100,000 for certain of these fees, which have not yet been
issued
,
was included in the Company’s accrued
expenses at September 30, 2017.
|
|
|
Grant
|
Expiration
|
Exercise
|
Number of
|
Compensation
|
|
Name
|
Date
|
Date
(1)
|
Price
(2)
|
Warrants
|
Expense
|
|
|
|
|
|
|
|
|
David
S. Boone
|
3/22/13
|
3/21/22
|
$
1.24
|
8,943
|
$
62,580
|
|
7/1/13
|
6/30/22
|
$
1.24
|
4,083
|
$
32,275
|
|
|
10/1/13
|
9/30/22
|
$
1.24
|
2,280
|
$
22,775
|
|
|
1/2/14
|
12/31/23
|
$
1.24
|
2,344
|
$
16,305
|
|
|
10/15/15
|
10/14/22
|
$
1.24
|
12,676
|
$
50,943
|
|
|
1/15/16
|
1/15/23
|
$
1.24
|
15,126
|
$
73,039
|
|
|
7/1/16
|
6/30/23
|
$
1.24
|
18,000
|
$
80,310
|
|
|
Karen
Macleod
|
7/1/16
|
6/30/23
|
$
1.24
|
9,000
|
$
37,154
|
|
9/30/16
|
9/30/21
|
$
1.15
|
3,529
|
$
15,000
|
|
|
10/1/16
|
9/30/21
|
$
1.15
|
5,882
|
$
25,000
|
|
|
1/1/17
|
12/31/21
|
$
1.15
|
9,191
|
$
25,000
|
|
|
4/1/17
|
3/31/22
|
$
1.15
|
12,195
|
$
25,000
|
|
|
7/1/17
(3)
|
6/30/22
|
$
1.15
|
13,812
|
$
25,000
|
|
|
10/1/17
(3)
|
9/30/22
|
$
1.15
|
21,008
|
$
25,000
|
|
|
1/1/18
(3)
|
12/31/22
|
$
1.05
|
33,784
|
$
25,000
|
|
|
|
|
|
|
||
|
Dirk
van Daele
|
10/15/15
|
10/14/22
|
$
1.24
|
6,338
|
$
29,690
|
|
1/15/16
|
1/15/23
|
$
1.24
|
7,563
|
$
36,520
|
|
|
7/1/16
|
6/30/23
|
$
1.24
|
9,000
|
$
40,155
|
|
|
|
|
|
|
||
|
Dr.
Ray Johnson
|
10/1/16
|
9/30/21
|
$
1.24
|
5,882
|
$
32,904
|
|
1/1/17
|
12/31/21
|
$
1.24
|
9,191
|
$
34,454
|
|
|
4/1/17
|
3/31/22
|
$
1.24
|
12,195
|
$
25,744
|
|
|
7/1/17
|
6/30/22
|
$
1.24
|
13,812
|
$
25,554
|
|
|
10/1/17
|
9/30/22
|
$
1.24
|
21,008
|
$
25,000
|
|
|
1/1/2018
|
12/31/22
|
$
1.05
|
33,784
|
$
25,000
|
|
|
(1)
|
Reflects the expiration dates following the expiration date
modification of the warrants reported herein, as approved by the
Board of Directors on May 11, 2017.
|
|
(2)
|
Reflects the exercise prices following the repricing of the
warrants reported herein, as approved by the Board of Directors on
November 30, 2017 and January 26, 2018.
|
|
(3)
|
On January 26, 2018, at the request of Ms. Macleod, these warrants
were exchanged for an aggregate amount of 52,761 share of Common
Stock.
|
|
Plan category
|
Number of securities to be issued upon exercise of outstanding
options, warrants and rights
|
Weighted-average exercise price of outstanding options,
warrants and rights
|
Number of securities remaining available for future issuance under
equity compensation plans (excluding securities reflected in column
(a))
|
|
|
(a)
|
(b)
|
(c)
|
|
Equity
compensation plans approved by security holders
|
488,011
|
$
8.51
|
38,292
|
|
|
|
|
|
|
Equity
compensation plans not approved by security holders
|
59,684
(1)
|
-
|
-
|
|
|
|
|
|
|
Total
|
547,695
|
$
8.51
|
38,292
|
|
(1)
|
This excludes 966,691 warrants and shares of Common Stock awarded
subsequent to September 30, 2017, 906,092 of which warrants and
shares were issued on May 1, 2018.
|
|
|
Sept. 30,
2017
|
Sept. 30,
2016
|
|
Beginning
balance
|
$
3,289,879
|
$
3,501,410
|
|
Payment
of shares for achieving performance milestones
|
(75,939
)
|
(211,531
)
|
|
Adjustment
to Track Group Analytics stock payable
|
(213,940
)
|
-
|
|
Adjustment
to GPS Global stock payable
|
(3,000,000
)
|
-
|
|
Ending
balance
|
-
|
$
3,289,879
|
|
|
Sept. 30,
2017
|
Sept. 30,
2016
|
|
Related
party loan with an interest rate of 3% and 8% per annum for undrawn
and borrowed funds, respectively. Principal and interest due
September 30, 2020.
|
$
3,399,644
|
$
3,399,644
|
|
Total
related-party debt obligations
|
$
3,399,644
|
$
3,399,644
|
|
●
|
Mr. Poli, our Chief Financial Officer, filed a Form 4 reporting one
late transaction;
|
|
●
|
Mr. Boone, a member of our Board of Directors during the year ended
September 30, 2017, filed a Form 4 reporting four late
transactions; and
|
|
●
|
Mr. van Daele, a member of our Board of Directors during the year
ended September 30, 2017, filed a Form 4 reporting one late
transaction.
|
|
Name and Address of
|
Common Stock
|
|
|
Beneficial Owner
(1)
|
Shares
|
%
|
|
ETS Limited
(2)
|
4,871,745
|
42.7
%
|
|
Safety Invest S.A., Compartment Secure
I
(3)
|
1,740,697
|
15.3
%
|
|
Advance Technology Investors LLC
(4)
|
540,865
|
4.8
%
|
|
|
|
|
|
Directors and Named Executive Officers:
|
|
|
|
Guy Dubois
(5)
|
653,568
|
5.4
%
|
|
Peter Poli
(6)
|
183,640
|
1.6
%
|
|
Derek Cassell
(7)
|
317,209
|
2.8
%
|
|
Karen Macleod
(8)
|
94,939
|
*
|
|
Karim Sehnaoui
(9)
|
14,021
|
*
|
|
All
directors and executive officers as a group
(6
persons)
|
1,263,377
|
9.8
%
|
|
(1)
|
Except as otherwise indicated, the business address for these
beneficial owners is c/o the Company, 200 E. 5th Avenue, Suite 100,
Naperville, Illinois 60563.
|
|
(2)
|
Address is c/o Mourant Ozannes Corporate Services (Cayman) Limited,
94 Solaris Avenue, Camana Bay, PO Box 1348, Grand Cayman KY1-1108,
Cayman Islands. Holding information is based on Amendment No.
2 to Schedule 13D filed by ADS Securities LLC on February 9,
2018.
|
|
(3)
|
Secure I is a compartment of Safety Invest S.A.
(“
Safety
”), a company established under the
Luxembourg Securitization Law and incorporated as a
“société anonyme” under the laws of the Grand
Duchy of Luxembourg whose principal business is to enter into one
or more securitization transactions. Holding information is based
on the Company records.
|
|
(4)
|
Address is 154 Rock Hill Road, Spring Valley, New York 10977.
Holding information is based on Company records.
|
|
(5)
|
Holdings consist of 315,331 shares of Common Stock owned of
record and 338,237 shares of Common Stock issuable upon exercise of
stock purchase warrants, exercisable within 60 days of July 12,
2018.
|
|
(6)
|
Holdings consist of 133,640 shares of Common Stock and 50,000
shares of Common Stock issuable upon exercise of stock purchase
warrants, exercisable within 60 days of July 12, 2018.
|
|
(7)
|
Holdings include 317,209 shares of Common Stock owned of
record.
|
|
(8)
|
Holdings includes 55,142 shares of Common Stock owned of
record and 39,797 shares of Common Stock issuable upon exercise of
stock purchase warrants, exercisable within 60 days of July 12,
2018.
|
|
(9)
|
Holdings include 14,021 shares of Common Stock owned of
record.
|
|
|
|
|
|
[X] Please mark your votes as indicated in this
example.
|
|||||||||||
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
CONSENT (FOR)
|
|
CONSENT WITHELD (AGAINST)
|
|
ABSTAIN
|
|
|
|
|
APPROVAL OF THE ELECTION OF THE FOLLOWING INDIVIDUALS AS MEMBERS OF
OUR BOARD OF DIRECTORS, TO SERVE UNTIL THE NEXT ANNUAL MEETING OF
STOCKHOLDERS OR UNTIL THEIR RESPECTIVE SUCCESSORS ARE ELECTED AND
QUALIFIED, OR UNTIL THEIR EARLIER RESIGNATION OR
REMOVAL:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Guy Dubois
|
|
|
|
|
|
[ ]
|
|
[ ]
|
|
[ ]
|
|
|
|
|
Karen Macleod
|
|
|
|
|
|
[ ]
|
|
[ ]
|
|
[ ]
|
|
|
|
|
Karim Sehnaoui
|
|
|
|
|
|
[ ]
|
|
[ ]
|
|
[ ]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
APPROVAL OF THE RATIFICATION OF THE APPOINTMENT OF EIDE BAILLY, LLP
TO SERVE AS THE COMPANY’S REGISTERED PUBLIC ACCOUNTING FIRM
FOR THE YEAR ENDED SEPTEMBER 30, 2018
|
|
|
|
|
|
[ ]
|
|
[ ]
|
|
[ ]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This Written Consent, when properly executed and returned to the
Company, will be voted in the manner directed herein by the
undersigned. IF NO DIRECTION IS MADE FOR THE PROPOSAL, THIS
CONSENT, IF SO EXECUTED AND RETURNED, WILL BE VOTED FOR THE
PROPOSAL. When shares of Common Stock are held by joint tenants,
both should sign. When signing as attorney, executor,
administrator, trustee or guardian, give full legal title as such.
If a corporation, sign in full corporate name by president or other
authorized officer. If a partnership, please sign in partnership
name by authorized person.
ALL CONSENTS MUST BE RECEIVED BY 5:00 P.M. CENTRAL TIME, ON THE
EXPIRATION DATE.
|
|
IMPORTANT:
This Consent
Card must be signed exactly as your name appears hereon. If more
than one name appears, all persons so designated should sign.
Attorneys, executors, administrators, trustees and guardians should
indicate their capacities. If the signer is a corporation, please
print full corporate name and indicate capacity of duly authorized
officer executing on behalf of the corporation. If the signer is a
partnership, please print full partnership name and indicate
capacity of duly authorized person executing on behalf of the
partnership.
Dated: ________________________, ______
|
|
|
||
|
|
(Print Name of Stockholder)
|
|
|
|
||
|
(Signature of Stockholder)
|
||
|
|
||
|
(Second Signature if held jointly)
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|